How many drugs treat Glioblastoma multiforme?

Drug Landscape tracks 3 marketed treatments for Glioblastoma multiforme (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/glioblastoma-multiforme.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Glioblastoma multiforme — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Glioblastoma multiforme (disease) competitive landscape: 3 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

3 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Glioblastoma multiforme, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Bevacizumab	Bevacizumab-Bvzr	Roche	Monoclonal antibody	Vascular Endothelial Growth Factor (VEGF)	2004-01-01
Avastin	bevacizumab	Roche	Vascular Endothelial Growth Factor Inhibitor [EPC]	Vascular endothelial growth factor A	2004-01-01
Avastin	Avastin	Washington University School of Medicine		Vascular endothelial growth factor A

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Roche · 2 drugs in Glioblastoma multiforme
Washington University School of Medicine · 1 drug in Glioblastoma multiforme

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Glioblastoma multiforme:

Cite this brief

Drug Landscape (2026). Glioblastoma multiforme — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/glioblastoma-multiforme. Accessed 2026-06-10.

Glioblastoma multiforme full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing